|
|
Volumn 2014, Issue , 2014, Pages
|
|
Anti-inflammatory therapy in diabetic retinopathy
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADRENOMEDULLIN;
ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE;
BRAIN DERIVED NEUROTROPHIC FACTOR;
COMPLEMENT FACTOR H;
GLUCAGON LIKE PEPTIDE 1;
GLUTAMATE AMMONIA LIGASE;
INTERLEUKIN 17;
NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE;
REACTIVE OXYGEN METABOLITE;
SYNAPTOPHYSIN;
TRANSFORMING GROWTH FACTOR BETA1;
VASCULOTROPIN;
ANTIINFLAMMATORY AGENT;
ARTERIAL WALL THICKNESS;
BLINDNESS;
CELL DENSITY;
CENTRAL CORNEAL THICKNESS;
CORNEA ENDOTHELIUM;
DIABETIC MACULAR EDEMA;
DIABETIC PATIENT;
DIABETIC RETINOPATHY;
EDITORIAL;
ENDOTHELIUM CELL;
HUMAN;
HYPERGLYCEMIA;
HYPERLIPIDEMIA;
HYPERTENSION;
INSULIN INFUSION;
METABOLIC REGULATION;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PRIORITY JOURNAL;
RETINA MACULOPATHY;
RETINA NEOVASCULARIZATION;
RISK FACTOR;
INFLAMMATION;
METABOLISM;
ANTI-INFLAMMATORY AGENTS;
DIABETIC RETINOPATHY;
HUMANS;
INFLAMMATION;
RISK FACTORS;
|
|
EID: 84896912412
PISSN: 09629351
EISSN: 14661861
Source Type: Journal
DOI: 10.1155/2014/947896 Document Type: Editorial |
|
Times cited : (8)
|
|
References (3)
|
